My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 333

    1.

    Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.

    Mohr AM, Holcomb JB, Dutton RP, Duranteau J.

    Crit Care. 2005;9 Suppl 5:S37-42. Epub 2005 Oct 7. Review.PMID: 16221318 [PubMed - indexed for MEDLINE]Related articles

    2.

    Recombinant-activated coagulation factor VIIa (NovoSeven): current development.

    Weiskopf RB.

    Vox Sang. 2007 May;92(4):281-8. Review.PMID: 17456151 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

    Grounds RM, Bolan C.

    Crit Care. 2005;9 Suppl 5:S29-36. Epub 2005 Oct 7. Review. Erratum in: Crit Care. 2005;9(6):560. PMID: 16221317 [PubMed - indexed for MEDLINE]Related articles

    4.

    Safety profile of recombinant factor VIIa.

    Roberts HR, Monroe DM 3rd, Hoffman M.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):101-8. Review.PMID: 14872430 [PubMed - indexed for MEDLINE]Related articles

    5.

    Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.

    Martinowitz U, Michaelson M; Israeli Multidisciplinary rFVIIa Task Force.

    J Thromb Haemost. 2005 Apr;3(4):640-8.PMID: 15842347 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.

    Levi M, Peters M, Büller HR.

    Crit Care Med. 2005 Apr;33(4):883-90. Review.PMID: 15818119 [PubMed - indexed for MEDLINE]Related articles

    7.

    Recombinant activated factor VII for adjunctive hemorrhage control in trauma.

    Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M.

    J Trauma. 2001 Sep;51(3):431-8; discussion 438-9.PMID: 11535886 [PubMed - indexed for MEDLINE]Related articles

    8.

    Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.

    Selin S, Tejani A.

    Issues Emerg Health Technol. 2006 Mar;(82):1-4.PMID: 16602203 [PubMed - indexed for MEDLINE]Related articles

    9.

    Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.

    Kluger Y, Riou B, Rossaint R, Rizoli SB, Boffard KD, Choong PI, Warren B, Tillinger M.

    Crit Care. 2007;11(4):R85.PMID: 17686152 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

    Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E.

    Can J Anaesth. 2002 Dec;49(10):S15-20.PMID: 12546003 [PubMed - indexed for MEDLINE]Related articles

    11.

    The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review.

    Mathew P.

    Thromb Haemost. 2004 Oct;92(4):738-46. Review.PMID: 15467904 [PubMed - indexed for MEDLINE]Related articles

    12.

    To general haemostasis--the evidence-based route.

    Erhardtsen E.

    Pathophysiol Haemost Thromb. 2002;32 Suppl 1:47-52. Review.PMID: 12214148 [PubMed - indexed for MEDLINE]Related articles

    13.

    Dosing with recombinant factor viia based on current evidence.

    Hedner U.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):35-9. Review.PMID: 14872419 [PubMed - indexed for MEDLINE]Related articles

    14.

    Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

    Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y; NovoSeven Trauma Study Group.

    J Trauma. 2005 Jul;59(1):8-15; discussion 15-8.PMID: 16096533 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recombinant factor VIIa: a review on its clinical use.

    Franchini M.

    Int J Hematol. 2006 Feb;83(2):126-38. Review.PMID: 16513530 [PubMed - indexed for MEDLINE]Related articles

    16.

    Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.

    Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

    J Pediatr Hematol Oncol. 2007 Mar;29(3):145-50.PMID: 17356391 [PubMed - indexed for MEDLINE]Related articles

    17.

    Potential role of recombinant factor VIIa as a hemostatic agent.

    Hedner U, Erhardtsen E.

    Clin Adv Hematol Oncol. 2003 Feb;1(2):112-9. Review.PMID: 16224390 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors.

    Seremetis S.

    Blood Coagul Fibrinolysis. 2003 Jun;14 Suppl 1:S29-30. Review.PMID: 14567532 [PubMed - indexed for MEDLINE]Related articles

    19.

    "Off-license" use of recombinant activated factor VII.

    Ghorashian S, Hunt BJ.

    Blood Rev. 2004 Dec;18(4):245-59. Review.PMID: 15501553 [PubMed - indexed for MEDLINE]Related articles

    20.

    Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.

    Grounds M.

    Blood Rev. 2003 Sep;17 Suppl 1:S11-21. Review.PMID: 14697209 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity